Wells Fargo
INKT icon

Wells Fargo’s MiNK Therapeutics INKT Stock Holding History

Wells Fargo’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23 Buy
+2
New +$23 ﹤0.01% 6905
2026
Q1 		– Sell
-20
Closed -$223 – 7328
2025
Q4 		$223 Buy
+20
New +$258 ﹤0.01% 6385
2025
Q3 		– Sell
-849
Closed -$6.27K – 7236
2025
Q2 		$6.27K Buy
849
+1
+0.1% +$8 ﹤0.01% 6049
2025
Q1 		$7.33K Sell
848
-160
-16% -$1.43K ﹤0.01% 5955
2024
Q4 		$7.02K Sell
1,008
-45
-4% -$306 ﹤0.01% 6003
2024
Q3 		$7.9K Sell
1,053
-33
-3% -$280 ﹤0.01% 5846
2024
Q2 		$10.3K Sell
1,086
-16
-1% -$156 ﹤0.01% 5731
2024
Q1 		$10K Sell
1,102
-51
-4% -$473 ﹤0.01% 5762
2023
Q4 		$12.3K Sell
1,153
-60
-5% -$626 ﹤0.01% 5778
2023
Q3 		$13.3K Sell
1,213
-1,529
-56% -$24.9K ﹤0.01% 5731
2023
Q2 		$57.6K Buy
2,742
+2,739
+91,300% +$54.9K ﹤0.01% 5365
2023
Q1 		$63 Hold
3
– – ﹤0.01% 7054
2022
Q4 		$84 Hold
3
– – ﹤0.01% 6840
2022
Q3 		$0 Buy
3
+1
+50% +$20 ﹤0.01% 6974
2022
Q2 		$0 Sell
2
-43
-96% -$810 ﹤0.01% 7123
2022
Q1 		$1K Sell
45
-76
-63% -$2.28K ﹤0.01% 6808
2021
Q4 		$5K Buy
+121
New +$14.4K ﹤0.01% 6704

Other funds holding INKT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Wells Fargo's INKT Position: Q2 2026 in Review

Wells Fargo opened a new position in MiNK Therapeutics (INKT) in Q2 2026: 2 shares worth $23. The stake represents ﹤0.01% of the portfolio and ranks #6905 among its holdings. This is a return to the name: Wells Fargo previously reported a position in INKT as recently as Q4 2025.

Wells Fargo first reported a position in INKT in Q4 2021 and has held it in 17 quarters since. The position peaked at $57.6K in Q2 2023. 27 funds tracked by Wall St. Rank hold INKT as of Q2 2026.

  • Wells Fargo held 2 shares of MiNK Therapeutics worth $23 as of Q2 2026.
  • MiNK Therapeutics was a new Wells Fargo position in Q2 2026.
  • MiNK Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6905 holding.
  • Wells Fargo first reported a position in MiNK Therapeutics in Q4 2021 and has held it in 17 quarters since.
  • Wells Fargo's MiNK Therapeutics position peaked at $57.6K in Q2 2023.
  • 27 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.